Others include ASX-listed Emyria, which is backed by the Forrest family, and Entropy Neurodynamics, also ASX-listed, which has developed an intravenous infusion of psilocybin.

Click the link below to read the full article.

https://www.afr.com/companies/healthcare-and-fitness/black-market-to-biotech-inside-australia-s-legal-psychedelic-factory-20260526-p600ty